Bubalus kerabau (carabao): 129643179
Help
Entry
129643179 CDS
T11435
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X1
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
bke Bubalus kerabau (carabao)
Pathway
bke01524
Platinum drug resistance
bke04010
MAPK signaling pathway
bke04115
p53 signaling pathway
bke04148
Efferocytosis
bke04210
Apoptosis
bke04215
Apoptosis - multiple species
bke04623
Cytosolic DNA-sensing pathway
bke04650
Natural killer cell mediated cytotoxicity
bke04657
IL-17 signaling pathway
bke04668
TNF signaling pathway
bke04726
Serotonergic synapse
bke04932
Non-alcoholic fatty liver disease
bke04933
AGE-RAGE signaling pathway in diabetic complications
bke04936
Alcoholic liver disease
bke05010
Alzheimer disease
bke05012
Parkinson disease
bke05014
Amyotrophic lateral sclerosis
bke05016
Huntington disease
bke05020
Prion disease
bke05022
Pathways of neurodegeneration - multiple diseases
bke05132
Salmonella infection
bke05133
Pertussis
bke05134
Legionellosis
bke05145
Toxoplasmosis
bke05146
Amoebiasis
bke05152
Tuberculosis
bke05160
Hepatitis C
bke05161
Hepatitis B
bke05162
Measles
bke05163
Human cytomegalovirus infection
bke05164
Influenza A
bke05165
Human papillomavirus infection
bke05167
Kaposi sarcoma-associated herpesvirus infection
bke05168
Herpes simplex virus 1 infection
bke05169
Epstein-Barr virus infection
bke05170
Human immunodeficiency virus 1 infection
bke05200
Pathways in cancer
bke05203
Viral carcinogenesis
bke05205
Proteoglycans in cancer
bke05206
MicroRNAs in cancer
bke05210
Colorectal cancer
bke05222
Small cell lung cancer
bke05416
Viral myocarditis
bke05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
bke00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
129643179 (CASP3)
04668 TNF signaling pathway
129643179 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
129643179 (CASP3)
09143 Cell growth and death
04210 Apoptosis
129643179 (CASP3)
04215 Apoptosis - multiple species
129643179 (CASP3)
04115 p53 signaling pathway
129643179 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
129643179 (CASP3)
04650 Natural killer cell mediated cytotoxicity
129643179 (CASP3)
04657 IL-17 signaling pathway
129643179 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
129643179 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
129643179 (CASP3)
05206 MicroRNAs in cancer
129643179 (CASP3)
05205 Proteoglycans in cancer
129643179 (CASP3)
05203 Viral carcinogenesis
129643179 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
129643179 (CASP3)
05222 Small cell lung cancer
129643179 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
129643179 (CASP3)
05161 Hepatitis B
129643179 (CASP3)
05160 Hepatitis C
129643179 (CASP3)
05164 Influenza A
129643179 (CASP3)
05162 Measles
129643179 (CASP3)
05168 Herpes simplex virus 1 infection
129643179 (CASP3)
05163 Human cytomegalovirus infection
129643179 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
129643179 (CASP3)
05169 Epstein-Barr virus infection
129643179 (CASP3)
05165 Human papillomavirus infection
129643179 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
129643179 (CASP3)
05133 Pertussis
129643179 (CASP3)
05134 Legionellosis
129643179 (CASP3)
05152 Tuberculosis
129643179 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
129643179 (CASP3)
05145 Toxoplasmosis
129643179 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
129643179 (CASP3)
05012 Parkinson disease
129643179 (CASP3)
05014 Amyotrophic lateral sclerosis
129643179 (CASP3)
05016 Huntington disease
129643179 (CASP3)
05020 Prion disease
129643179 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
129643179 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
129643179 (CASP3)
05416 Viral myocarditis
129643179 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
129643179 (CASP3)
04932 Non-alcoholic fatty liver disease
129643179 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
129643179 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
129643179 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
bke01002
]
129643179 (CASP3)
Enzymes [BR:
bke01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
129643179 (CASP3)
Peptidases and inhibitors [BR:
bke01002
]
Cysteine peptidases
Family C14: caspase family
129643179 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Other DBs
NCBI-GeneID:
129643179
NCBI-ProteinID:
XP_055423406
LinkDB
All DBs
Position
2:30539465..30562661
Genome browser
AA seq
277 aa
AA seq
DB search
MSMENTENSVDSKSIKTSETKILHGSKSMDSGISLEESYKMDYPEMGLCIIINNKNFHEN
TGMACRSGTDVDAANLRETFMSLKYEVRIKNDLTCKEMLELMSNVSKEDHSRRSSFICVL
LSHGEEGIIFGTNGPVDLKKLASFFRGDCCRSLTGKPKLFIIQACRGTELDCGIETDSGA
EDDMACQKIPVEADFLYAYSTAPGYFSWRNAKYGSWFIQALCEMLKKYAHKLDLTRILTR
VNRKVAIEYESFSTDSAFHAKKQIPCIMSMLTKELYF
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atgtccatggagaacactgaaaattcagtggattcaaaatccattaaaacttcagagaca
aagatcttacatggaagcaaatcaatggactctggaatatccttggaagagagttacaaa
atggattatcctgaaatgggtttgtgtataataatcaataataagaacttccacgaaaat
actggcatggcctgtcgatctggtacagatgtggatgcggcaaacctcagggaaacattc
atgagcttgaaatacgaagtcaggattaaaaatgatcttacatgtaaagaaatgttggaa
ttaatgagcaacgtttctaaagaagaccatagcagaaggagcagttttatttgcgtgctt
ctaagccatggtgaagaaggaatcatttttggaaccaatggacctgtcgatctgaaaaaa
ctagcaagtttcttcagaggggactgttgcagaagtctgactggaaaacccaaacttttc
attattcaggcctgccgaggcacagaactggactgtggtattgagacagacagtggtgct
gaggatgacatggcctgtcagaaaataccagttgaggcagacttcttgtacgcatattct
acagcacctggttacttttcctggcgaaacgcaaagtacggatcctggttcatccaggct
ctttgtgagatgctgaaaaagtacgctcacaagctcgacctcacgcgcattcttactcgg
gttaaccgaaaggtagcaatagaatatgagtccttttctaccgattctgcttttcatgca
aagaaacagattccttgtattatgtctatgctcacaaaagaactgtatttctaa
DBGET
integrated database retrieval system